Agilent Technologies ClearSeq Comprehensive Cancer research panel
Agilent Technologies has launched the ClearSeq Comprehensive Cancer research panel, designed to improve the speed and accuracy of clinical cancer research. The product will enable researchers to rapidly and accurately identify disease-associated variants in tumour samples - information that can be vital to research in cancer treatments.
The off-the-shelf cancer research panel provides an accelerated solution for the analysis of many oncogenes and tumour suppressors. The panel is the latest addition to Agilent’s growing portfolio of ClearSeq cancer research panels and targets 151 key oncology genes containing disease-associated variants. Designed with the clinical researcher in mind, the panel allows clinical researchers to rapidly profile multiple mutations present in cancer samples.
Phone: 03 9566 1117
ALA Scientific Instruments RuFus cell unroofing system for plasma membrane isolation
ALA Scientific Instruments offers RuFus, a complete and user-friendly system for performing cell...
Lonza plateable mouse hepatocytes
Lonza provides plateable mouse hepatocytes from the four most common research mouse strains,...
PEPperPRINT cLIFT peptide microarray platform
At the core of the technology is a laser-based transfer process that is designed to deposit amino...
